tiprankstipranks
ResMed upgraded to Buy from Neutral at UBS
PremiumThe FlyResMed upgraded to Buy from Neutral at UBS
22d ago
ResMed price target raised to $280 from $266 at KeyBanc
Premium
The Fly
ResMed price target raised to $280 from $266 at KeyBanc
22d ago
ResMed price target raised to $260 from $252 at Piper Sandler
Premium
The Fly
ResMed price target raised to $260 from $252 at Piper Sandler
22d ago
ResMed initiated with a Buy at Goldman Sachs
PremiumThe FlyResMed initiated with a Buy at Goldman Sachs
1M ago
ResMed initiated with a Neutral at Piper Sandler
Premium
The Fly
ResMed initiated with a Neutral at Piper Sandler
1M ago
CMS confirms to CNBC Medicare plans can now cover Zepbound for sleep apnea
Premium
The Fly
CMS confirms to CNBC Medicare plans can now cover Zepbound for sleep apnea
1M ago
ResMed price target raised to $283 from $280 at Baird
PremiumThe FlyResMed price target raised to $283 from $280 at Baird
4M ago
Closing Bell Movers: Deckers up 12% after earnings beat
Premium
The Fly
Closing Bell Movers: Deckers up 12% after earnings beat
4M ago
ResMed reports Q1 non-GAAP EPS $2.20, consensus $2.04
Premium
The Fly
ResMed reports Q1 non-GAAP EPS $2.20, consensus $2.04
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100